{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:48:32Z","timestamp":1789886912050,"version":"4.0.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.semarthrit.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T01:51:48Z","timestamp":1403747508000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Chronic arthritis and cardiovascular disease: Altered blood parameters give rise to a prothrombotic propensity"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-8640","authenticated-orcid":false,"given":"Jilke","family":"Beinsberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.M.","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.E.M.","family":"Cosemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.06.006_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2013-204767","article-title":"Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system","volume":"73","author":"van den Oever","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib3","first-page":"612","article-title":"Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Papagoras","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?","volume":"67","author":"Gonzalez","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cvr\/cvt110","article-title":"The effects of arterial flow on platelet activation, thrombus growth, and stabilization","volume":"99","author":"Cosemans","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00296-010-1446-x","article-title":"Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature10659","article-title":"New gene functions in megakaryopoiesis and platelet formation","volume":"480","author":"Gieger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01419947","article-title":"Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis","volume":"16","author":"Ertenli","year":"1996","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1181928","article-title":"Platelets amplify inflammation in arthritis via collagen-dependent microparticle production","volume":"327","author":"Boilard","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib12","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood-2012-02-413047","article-title":"Platelets can enhance vascular permeability","volume":"120","author":"Cloutier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tcm.2005.03.003","article-title":"Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment","volume":"15","author":"Heemskerk","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib14","first-page":"107","article-title":"Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release","volume":"3","author":"Vasina","year":"2013","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","article-title":"Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/187152810793938008","article-title":"Platelets and platelet-derived microparticles in vascular inflammatory disease","volume":"9","author":"Vasina","year":"2010","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib17","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","article-title":"Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa","volume":"10","author":"Van der Meijden","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib18","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"Platelet functions beyond hemostasis","volume":"7","author":"Smyth","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib19","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCRESAHA.113.300512","article-title":"Platelets as cellular effectors of inflammation in vascular diseases","volume":"112","author":"Rondina","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/03009748209098179","article-title":"Platelet function in rheumatoid arthritis","volume":"11","author":"Colli","year":"1982","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/rheumatology\/kep377","article-title":"Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target","volume":"49","author":"Mac Mullan","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/03009748109095299","article-title":"Investigation of blood platelets in synovial fluid from patients with rheumatoid arthritis","volume":"10","author":"Endresen","year":"1981","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1981.tb29717.x","article-title":"A comparative study of platelet reactivity in arthritis","volume":"370","author":"Riddle","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.42.5.545","article-title":"Thrombocytosis of active rheumatoid disease","volume":"42","author":"Farr","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3899\/jrheum.110741","article-title":"Platelet reactivity and disease activity in subjects with psoriatic arthritis","volume":"39","author":"Di Minno","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib26","doi-asserted-by":"crossref","first-page":"R536","DOI":"10.1186\/ar1706","article-title":"Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes","volume":"7","author":"Berckmans","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09537100701210057","article-title":"Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis?","volume":"19","author":"Pamuk","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1189\/jlb.0312151","article-title":"Platelets: key players in vascular inflammation","volume":"92","author":"Projahn","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3048","article-title":"Therapeutic targeting of chemokine interactions in atherosclerosis","volume":"9","author":"Koenen","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/03009740701218741","article-title":"In vivo interactions of platelets and leucocytes with the endothelium in murine antigen-induced arthritis: the role of P-selectin","volume":"36","author":"Schmitt-Sody","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","article-title":"Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization","volume":"104","author":"Lincoff","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCRESAHA.108.190611","article-title":"Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques","volume":"105","author":"Eisenhardt","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-\u03b1 in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin Sci"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib34","first-page":"89","article-title":"Vascular function and inflammation in rheumatoid arthritis: the role of physical activity","volume":"4","author":"Metsios","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1657562","article-title":"Cytokines: triggers of clinical thrombotic disease","volume":"78","author":"ten Cate","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0038-1657561","article-title":"Cytokine activation of endothelial cells: new molecules for an old paradigm","volume":"78","author":"Mantovani","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib37","first-page":"967","article-title":"Cytokines and hemostasis","volume":"85","author":"Grignani","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2515","article-title":"Vascular involvement in rheumatic diseases: \u201cvascular rheumatology\u201d","volume":"10","author":"Szekanecz","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib39","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/107999099314234","article-title":"Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease","volume":"19","author":"Krishnaswamy","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib41","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis-insidious, unpredictable and deadly","volume":"17","author":"Jackson","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib42","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1186\/ar4117","article-title":"Autoantibody-mediated arthritis in the absence of C3 and activating Fc\u03b3 receptors: C5 is activated by the coagulation cascade","volume":"14","author":"Auger","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib43","first-page":"3517","article-title":"Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis","volume":"121","author":"Song","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib44","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","article-title":"Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps","volume":"73","author":"Pratesi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","article-title":"COX-2 inhibitors and cardiovascular risk","volume":"50","author":"Funk","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(13)61128-9","article-title":"High-dose non-steroidal anti-inflammatories: painful choices","volume":"382","author":"Griffin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"Gossec","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib48","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib49","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib50","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib51","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib52","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib53","first-page":"2347","article-title":"Enhanced Fc\u03b3 receptor I, \u03b1M\u03b22 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets","volume":"31","author":"Bunescu","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib54","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bjp.0707364","article-title":"Novel uses for anti-platelet agents as anti-inflammatory drugs","volume":"152","author":"Pitchford","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib55","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.2174\/138161212802481264","article-title":"Anti-inflammatory effects of anti-platelet treatment in atherosclerosis","volume":"18","author":"Arazi","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib56","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cccn.2003.12.030","article-title":"Relationships between platelets and inflammatory markers in rheumatoid arthritis","volume":"343","author":"Milovanovic","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jbspin.2007.06.016","article-title":"Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis","volume":"75","author":"Kisacik","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/09537100903474373","article-title":"The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity","volume":"21","author":"Yazici","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/09537100903470306","article-title":"The platelet functions in patients with ankylosing spondylitis: anti-TNF-\u03b1 therapy decreases the mean platelet volume and platelet mass","volume":"21","author":"Yazici","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","article-title":"Mean platelet volume in psoriasis and psoriatic arthritis","volume":"29","author":"Canpolat","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib62","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ard.35.2.138","article-title":"Thrombocytosis in rheumatoid arthritis","volume":"35","author":"Hutchinson","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00683878","article-title":"Platelets in the synovial fluid of patients with rheumatoid arthritis","volume":"4","author":"Farr","year":"1984","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00270285","article-title":"Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis","volume":"9","author":"Endresen","year":"1989","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib65","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.11190","article-title":"sE-selectin for stratifying outcome in rheumatoid arthritis","volume":"49","author":"Egerer","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib66","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2362.2011.02607.x","article-title":"An observational study of endothelial function in early arthritis","volume":"42","author":"Foster","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib67","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/art.10312","article-title":"Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis","volume":"46","author":"Knijff-Dutmer","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib68","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10067-008-0847-7","article-title":"The significance of platelet activation in ankylosing spondylitis","volume":"27","author":"Wang","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib69","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/art.10587","article-title":"Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism","volume":"46","author":"Berckmans","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib70","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3899\/jrheum.111073","article-title":"Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis","volume":"39","author":"Sari","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib71","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10067-007-0550-0","article-title":"The significance of platelet activation in rheumatoid arthritis","volume":"26","author":"Wang","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/09537100903165174","article-title":"Elevated platelet\u2013monocyte complexes in patients with psoriatic arthritis","volume":"20","author":"Pamuk","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","article-title":"A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, l-selectin and P-selectin) in rheumatoid arthritis","volume":"36","author":"Littler","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s100670050047","article-title":"Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases","volume":"18","author":"Sfikakis","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.0300-9475.2004.01389.x","article-title":"Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis","volume":"59","author":"Ates","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib76","first-page":"875","article-title":"Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis","volume":"29","author":"Wallberg-Jonsson","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib77","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10067-006-0338-7","article-title":"Common carotid intima\u2013media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors","volume":"26","author":"Daza","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaut.2008.07.002","article-title":"Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-\u03b1 blockade","volume":"31","author":"Ingegnoli","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib79","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijcard.2008.02.011","article-title":"Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction","volume":"129","author":"Maki-Petaja","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Sari","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10067-011-1760-z","article-title":"Evaluation of various endothelial biomarkers in ankylosing spondylitis","volume":"31","author":"Taylan","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib82","first-page":"2597","article-title":"Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis","volume":"28","author":"Jonsson","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib83","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/ard.61.8.726","article-title":"Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis","volume":"61","author":"Bresnihan","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib84","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3899\/jrheum.100668","article-title":"Assessment of subclinical vascular disease associated with ankylosing spondylitis","volume":"38","author":"Bodnar","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.04.031","article-title":"Effect of anti TNF-\u03b1 therapy on arterial diameter and wall shear stress and HDL cholesterol","volume":"177","author":"Irace","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib86","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/rheumatology\/ken386","article-title":"C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis","volume":"47","author":"Galarraga","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib87","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar3374","article-title":"The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study","volume":"13","author":"Sandoo","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.2007.086777","article-title":"Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade","volume":"68","author":"van Eijk","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib89","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V81.3.726.bloodjournal813726","article-title":"Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis","volume":"81","author":"Conway","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib90","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/030097498442415","article-title":"Soluble cell adhesion molecules: P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis","volume":"27","author":"Veale","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/rheumatology\/40.6.640","article-title":"Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis","volume":"40","author":"McEntegart","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib92","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1160\/TH10-02-0091","article-title":"Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition","volume":"104","author":"Undas","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib93","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/ard.52.9.643","article-title":"Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis","volume":"52","author":"Lau","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib94","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jbspin.2006.01.018","article-title":"Serum tissue factor levels correlate with inflammation in ankylosing spondylitis","volume":"73","author":"Wendling","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib95","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jbspin.2012.02.013","article-title":"Thrombin generation in rheumatoid arthritis","volume":"79","author":"Prati","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10067-010-1552-x","article-title":"Thrombin generation in ankylosing spondylitis","volume":"30","author":"Prati","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib97","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/ar606","article-title":"Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis","volume":"5","author":"Jin","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib98","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard.51.10.1117","article-title":"Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib99","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10067-004-0915-6","article-title":"Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level","volume":"23","author":"Cobankara","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00296-009-1345-1","article-title":"Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-\u03b1 therapy","volume":"30","author":"Gasparyan","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib101","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib102","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-a treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib103","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.20407","article-title":"Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody","volume":"51","author":"Gonzalez-Juanatey","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib104","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00296-006-0147-y","article-title":"Anti-tumour necrosis factor-\u03b1 therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis","volume":"26","author":"Bilsborough","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.06.006_bib105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10067-007-0803-y","article-title":"TNF-\u03b1 blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis","volume":"27","author":"Bosello","year":"2008","journal-title":"Clin Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214001620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214001620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T15:49:57Z","timestamp":1689349797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017214001620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0049017214001620"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.06.006","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic arthritis and cardiovascular disease: Altered blood parameters give rise to a prothrombotic propensity","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}